Saniona (OMX: SANION), a clinical stage biopharmaceutical company, today announced that the ongoing ion channel research collaboration with Boehringer Ingelheim has been extended with one year. "The p ...
Bell Potter thinks investors should be snapping up this stock while it is down in the dumps. The post Meet the dirt cheap ASX ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback